| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2021-06-19 22:01:09 UTC |
|---|
| Updated at | 2021-06-29 23:58:54 UTC |
|---|
| NP-MRD ID | NP0030737 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | D-friedomadeir-14-en-3beta-yl acetate |
|---|
| Provided By | JEOL Database |
|---|
| Description | (1S)-1beta,5bbeta,8,8,11abeta,13aalpha-Hexamethyl-3abeta-isopropyl-2,3,3a,4,5b,6,7,7aalpha,8,9,10,11,11a,11balpha,12,13,13a,13bbeta-octadecahydro-1H-cyclopenta[a]chrysen-9beta-ol acetate belongs to the class of organic compounds known as scalarane sesterterpenoids. These are sesterterpenoids with a structure based on the scalarane backbone. Scalarane is a tetracyclic compound, which is similar the homoandrostane with five methyl groups at the 4-, 4-, 8-, 17-, 17a-positions. D-friedomadeir-14-en-3beta-yl acetate is found in Euphorbia stygiana. D-friedomadeir-14-en-3beta-yl acetate was first documented in 2003 (Lima, E. M.C., et al.). Based on a literature review very few articles have been published on (1S)-1beta,5bbeta,8,8,11abeta,13aalpha-Hexamethyl-3abeta-isopropyl-2,3,3a,4,5b,6,7,7aalpha,8,9,10,11,11a,11balpha,12,13,13a,13bbeta-octadecahydro-1H-cyclopenta[a]chrysen-9beta-ol acetate. |
|---|
| Structure | [H]C1=C2[C@@](C([H])([H])[H])(C([H])([H])C([H])([H])[C@@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]2([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]([H])(OC(=O)C([H])([H])[H])C([H])([H])C([H])([H])[C@]32C([H])([H])[H])[C@]2([H])[C@@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]2(C1([H])[H])C([H])(C([H])([H])[H])C([H])([H])[H] InChI=1S/C32H52O2/c1-20(2)32-18-10-21(3)27(32)31(9)16-12-24-29(7)17-14-26(34-22(4)33)28(5,6)23(29)11-15-30(24,8)25(31)13-19-32/h13,20-21,23-24,26-27H,10-12,14-19H2,1-9H3/t21-,23-,24+,26-,27-,29-,30+,31+,32+/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| (1S)-1b,5Bbeta,8,8,11abeta,13aalpha-hexamethyl-3abeta-isopropyl-2,3,3a,4,5b,6,7,7aalpha,8,9,10,11,11a,11balpha,12,13,13a,13bbeta-octadecahydro-1H-cyclopenta[a]chrysen-9b-ol acetate | Generator | | (1S)-1b,5Bbeta,8,8,11abeta,13aalpha-hexamethyl-3abeta-isopropyl-2,3,3a,4,5b,6,7,7aalpha,8,9,10,11,11a,11balpha,12,13,13a,13bbeta-octadecahydro-1H-cyclopenta[a]chrysen-9b-ol acetic acid | Generator | | (1S)-1beta,5Bbeta,8,8,11abeta,13aalpha-hexamethyl-3abeta-isopropyl-2,3,3a,4,5b,6,7,7aalpha,8,9,10,11,11a,11balpha,12,13,13a,13bbeta-octadecahydro-1H-cyclopenta[a]chrysen-9beta-ol acetic acid | Generator | | (1S)-1Β,5bbeta,8,8,11abeta,13aalpha-hexamethyl-3abeta-isopropyl-2,3,3a,4,5b,6,7,7aalpha,8,9,10,11,11a,11balpha,12,13,13a,13bbeta-octadecahydro-1H-cyclopenta[a]chrysen-9β-ol acetate | Generator | | (1S)-1Β,5bbeta,8,8,11abeta,13aalpha-hexamethyl-3abeta-isopropyl-2,3,3a,4,5b,6,7,7aalpha,8,9,10,11,11a,11balpha,12,13,13a,13bbeta-octadecahydro-1H-cyclopenta[a]chrysen-9β-ol acetic acid | Generator |
|
|---|
| Chemical Formula | C32H52O2 |
|---|
| Average Mass | 468.7660 Da |
|---|
| Monoisotopic Mass | 468.39673 Da |
|---|
| IUPAC Name | (1R,5R,8S,9R,10S,13R,14R,17S,19R)-1,8,10,14,18,18-hexamethyl-5-(propan-2-yl)pentacyclo[11.8.0.0^{2,10}.0^{5,9}.0^{14,19}]henicos-2-en-17-yl acetate |
|---|
| Traditional Name | (1R,5R,8S,9R,10S,13R,14R,17S,19R)-5-isopropyl-1,8,10,14,18,18-hexamethylpentacyclo[11.8.0.0^{2,10}.0^{5,9}.0^{14,19}]henicos-2-en-17-yl acetate |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H]C1=C2[C@@](C([H])([H])[H])(C([H])([H])C([H])([H])[C@@]3([H])[C@@]2(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]2([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]([H])(OC(=O)C([H])([H])[H])C([H])([H])C([H])([H])[C@]32C([H])([H])[H])[C@]2([H])[C@@]([H])(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]2(C1([H])[H])C([H])(C([H])([H])[H])C([H])([H])[H] |
|---|
| InChI Identifier | InChI=1S/C32H52O2/c1-20(2)32-18-10-21(3)27(32)31(9)16-12-24-29(7)17-14-26(34-22(4)33)28(5,6)23(29)11-15-30(24,8)25(31)13-19-32/h13,20-21,23-24,26-27H,10-12,14-19H2,1-9H3/t21-,23-,24+,26-,27-,29-,30+,31+,32+/m0/s1 |
|---|
| InChI Key | YXDJJHAAULKVPG-PVDRCGPPSA-N |
|---|
| Experimental Spectra |
|---|
|
| | Spectrum Type | Description | Depositor Email | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 300 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 100 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 400 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 500 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 600 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 700 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 800 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 900 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, CDCl3, simulated) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 100 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 125 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 150 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 175 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 200 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 225 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 25 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 250 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, chcl3, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | | Species Name | Source | Reference |
|---|
| Euphorbia stygiana | JEOL database | - Lima, E. M.C., et al., Phytochemistry 63, 421 (2003)
|
|
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as scalarane sesterterpenoids. These are sesterterpenoids with a structure based on the scalarane backbone. Scalarane is a tetracyclic compound, which is similar the homoandrostane with five methyl groups at the 4-, 4-, 8-, 17-, 17a-positions. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Prenol lipids |
|---|
| Sub Class | Sesterterpenoids |
|---|
| Direct Parent | Scalarane sesterterpenoids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Scalarane sesterterpenoid
- Steroid
- Carboxylic acid ester
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic homopolycyclic compound
|
|---|
| Molecular Framework | Aliphatic homopolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|